You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
Nephros to list on Nasdaq
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
The Market Intelligence Platform
Nephros Inc.'s common shares have been approved to list on Nasdaq, one of the largest stock exchanges in the world.
The South Orange, N.J.-based company, which develops and sells liquid purification filters, is listed on the OTCQB Venture Market, a stock market for over-the-counter securities.
The company expects its common stock to begin trading on Nasdaq on Aug. 14 under its current ticker symbol NEPH.